Zogenix, Inc. (Nasdaq: ZGNX) issued the following today:Rampant misinformation about Zohydro ER continues to be reported by the media and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE